These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8718785)
1. Cathepsin-D and TNF-alpha in bladder cancer. Salman T; el-Ahmady O; el-Shafee M; Omar S; Salman I Dis Markers; 1996 Mar; 12(4):253-9. PubMed ID: 8718785 [TBL] [Abstract][Full Text] [Related]
2. The clinical value of cathepsin-D and TNF-alpha in bladder cancer patients. Salman T; el-Ahmady O; el-Shafee M; Omar S; Salman I Anticancer Res; 1997; 17(4B):3087-90. PubMed ID: 9329608 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha production in schistosomiasis with carcinoma of urinary bladder. Raziuddin S; Masihuzzaman M; Shetty S; Ibrahim A J Clin Immunol; 1993 Jan; 13(1):23-9. PubMed ID: 8445042 [TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder. Iizumi T; Iiyama T; Tanaka W; Okada E; Kamiyama Y; Okano Y; Sato S; Yazaki T; Umeda T; Imamura T Urol Int; 1997; 59(2):81-7. PubMed ID: 9392054 [TBL] [Abstract][Full Text] [Related]
6. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience. el-Ahmady O; Halim AB; el-Din AG Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment. El-Aal AA; Emran AM; Al-Antably AS; El Saftawy EA; Bayoumy IR; Hassan NS; Badawi M Int J Immunopathol Pharmacol; 2015 Jun; 28(2):209-17. PubMed ID: 25926591 [TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer. Eissa S; Swellam M; El-Khouly IM; Kassim SK; Shehata H; Mansour A; Esmat M; Nossier AI; Hamdy MA; Awad NM; El-Ahmady O Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1657-64. PubMed ID: 21680534 [TBL] [Abstract][Full Text] [Related]
11. Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer. Koçak H; Oner-Iyidoğan Y; Koçak T; Oner P Clin Biochem; 2004 Aug; 37(8):673-8. PubMed ID: 15302609 [TBL] [Abstract][Full Text] [Related]
12. Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder. Tungekar MF; Linehan J J Clin Pathol; 1998 Aug; 51(8):583-7. PubMed ID: 9828815 [TBL] [Abstract][Full Text] [Related]
13. The activities of urinary alpha-esterases in bilharziasis and their possible role in the diagnosis of bilharzial bladder cancer in Egypt. el-Sewedy SM; Arafa A; Abdel-Aal G; Mostafa MH Trans R Soc Trop Med Hyg; 1978; 72(5):525-8. PubMed ID: 726000 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods. Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G; Titius BR J Clin Pathol; 1996 Jan; 49(1):57-64. PubMed ID: 8666688 [TBL] [Abstract][Full Text] [Related]
15. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Salim EI; Morimura K; Menesi A; El-Lity M; Fukushima S; Wanibuchi H Int J Cancer; 2008 Aug; 123(3):601-8. PubMed ID: 18478569 [TBL] [Abstract][Full Text] [Related]
16. Expression of cathepsin D in transitional cell bladder tumours. Lipponen PK J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318 [TBL] [Abstract][Full Text] [Related]
17. Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis. Aboushousha T; Hammam O; Helal N; El Dahshan S Asian Pac J Cancer Prev; 2018 Feb; 19(2):513-519. PubMed ID: 29480994 [TBL] [Abstract][Full Text] [Related]
18. Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis. Feng CC; Wang PH; Ding Q; Guan M; Zhang YF; Jiang HW; Wen H; Wu Z Urol Oncol; 2013 Feb; 31(2):241-6. PubMed ID: 21292512 [TBL] [Abstract][Full Text] [Related]
19. Cathepsin D in breast cancer tissue. Gonzalez Gancedo P; G-Casaus ML; Ruiz Cacho J; Calero F; Inocente JM; Gomez-Pastrana F; Ramon N Int J Biol Markers; 1990; 5(4):203-6. PubMed ID: 1965545 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]